Ethical and Legal Implications of Pharmacogenomics

Nature Reviews Genetics, Vol. 2, No. 2, pp. 228-231, 2001

4 Pages Posted: 5 Feb 2010

See all articles by Phyllis Griffin Epps

Phyllis Griffin Epps

Independent

Mark A. Rothstein

University of Louisville - Institute for Bioethics, Health Policy, and Law; University of Louisville - Louis D. Brandeis School of Law

Date Written: March 1, 2001

Abstract

Pharmacogenomics is the application of genomics technology to the discovery and development of drugs. A greater understanding of the way in which individuals with a particular genotype respond to a drug allows manufacturers to identify population subgroups that will benefit most from a particular drug. The increasing emphasis on pharmacogenomics is likely to raise ethical and legal questions regarding, among other things, the design of research studies, the construction of clinical trials and the pricing of drugs.

Keywords: genetic testing, alzheimers disease, long term care insurance, discrimination, long-term care

JEL Classification: K31, K32

Suggested Citation

Griffin Epps, Phyllis and Rothstein, Mark A., Ethical and Legal Implications of Pharmacogenomics (March 1, 2001). Nature Reviews Genetics, Vol. 2, No. 2, pp. 228-231, 2001. Available at SSRN: https://ssrn.com/abstract=1548037

Phyllis Griffin Epps

Independent

No Address Available

Mark A. Rothstein (Contact Author)

University of Louisville - Institute for Bioethics, Health Policy, and Law ( email )

Louisville, KY 40202
United States

HOME PAGE: http://www.louisville.edu/bioethics

University of Louisville - Louis D. Brandeis School of Law ( email )

Wilson W. Wyatt Hall
Louisville, KY 40292
United States

Register to save articles to
your library

Register

Paper statistics

Downloads
158
Abstract Views
1,357
rank
184,091
PlumX Metrics